These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


570 related items for PubMed ID: 19537379

  • 1. Treatment of pruritus in mild-to-moderate atopic dermatitis with a topical non-steroidal agent.
    Veraldi S, De Micheli P, Schianchi R, Lunardon L.
    J Drugs Dermatol; 2009 Jun; 8(6):537-9. PubMed ID: 19537379
    [Abstract] [Full Text] [Related]

  • 2. A multicenter, randomized, vehicle-controlled clinical study to examine the efficacy and safety of MAS063DP (Atopiclair) in the management of mild to moderate atopic dermatitis in adults.
    Abramovits W, Boguniewicz M, Adult Atopiclair Study Group.
    J Drugs Dermatol; 2006 Mar; 5(3):236-44. PubMed ID: 16573256
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A randomised, double-blind, vehicle-controlled study to evaluate the efficacy and safety of MAS063D (Atopiclair) in the treatment of mild to moderate atopic dermatitis.
    Belloni G, Pinelli S, Veraldi S.
    Eur J Dermatol; 2005 Mar; 15(1):31-6. PubMed ID: 15701590
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. MAS063DP is effective monotherapy for mild to moderate atopic dermatitis in infants and children: a multicenter, randomized, vehicle-controlled study.
    Boguniewicz M, Zeichner JA, Eichenfield LF, Hebert AA, Jarratt M, Lucky AW, Paller AS.
    J Pediatr; 2008 Jun; 152(6):854-9. PubMed ID: 18492531
    [Abstract] [Full Text] [Related]

  • 8. Onset of pruritus relief with pimecrolimus cream 1% in adult patients with atopic dermatitis: a randomized trial.
    Kaufmann R, Bieber T, Helgesen AL, Andersen BL, Luger T, Poulin Y, Al-Hafidh J, Paul C, multicentre investigator group.
    Allergy; 2006 Mar; 61(3):375-81. PubMed ID: 16436149
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cost-effectiveness study of pediatric atopic dermatitis in Asia: atopiclair vs. regular emollient (AD-ATOP).
    Tang MB, Leong KF, Ou LS, Munasir Z, Parekh PR, Azmi S, Low WH, Goh A.
    J Drugs Dermatol; 2015 Feb; 14(2):169-75. PubMed ID: 25689812
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Treatment of pruritus with topically applied opiate receptor antagonist.
    Bigliardi PL, Stammer H, Jost G, Rufli T, Büchner S, Bigliardi-Qi M.
    J Am Acad Dermatol; 2007 Jun; 56(6):979-88. PubMed ID: 17320241
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial.
    Gollnick H, Kaufmann R, Stough D, Heikkila H, Andriano K, Grinienko A, Jimenez P, Pimecrolimus Cream 1% in (adult) Eczema: Prevention of Progression Multicentre Investigator Study Group.
    Br J Dermatol; 2008 May; 158(5):1083-93. PubMed ID: 18341665
    [Abstract] [Full Text] [Related]

  • 16. Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study).
    Eberlein B, Eicke C, Reinhardt HW, Ring J.
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):73-82. PubMed ID: 18181976
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Topical diclofenac: new preparation. Moderate efficacy in actinic keratosis.
    Prescrire Int; 2004 Aug; 13(72):138-9. PubMed ID: 15532138
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 29.